← Back

Bay Island Cell raises $19.6M series a

Announced 11 July 2026

series a$19.6MDigital Health

Amount

$19.6M

Announced

11 Jul 2026

Company

Source

The Round

Bay Island Cell raised $19.6M in series a funding, announced on 11 July 2026, led by Shenzhen Capital Group, Songhe Capital, with participation from CoStone Capital, Orient Fortune Capital. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

About Bay Island Cell

Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu. Bay Island Cell is based in China and currently at series a stage, operating in Digital Health.

Investors

LeadShenzhen Capital Group, Songhe Capital

ParticipationCoStone Capital, Orient Fortune Capital

Market context

This funding event is a citable node in Fusion42's market graph: it links Bay Island Cell's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

Explore the market

FAQ

How much did Bay Island Cell raise?

Bay Island Cell raised $19.6M in its series-a round, announced 2026-07-11.

Who invested in Bay Island Cell's series-a round?

The round was led by Shenzhen Capital Group and Songhe Capital, with participation from CoStone Capital and Orient Fortune Capital.

What does Bay Island Cell do?

Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.

Verified 11 July 2026 · Sources: public filings